Megafor 10/160 mg
Valsartan · Amlodipine Besylate
Prescription medication · Combination
(株)Handok
MFDS item code 201309058 · Approved 2013.08.29
This product's status changed to Expired on 2023.08.29. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Treatment of essential hypertension not controlled with monotherapy
This medication is used for patients with essential hypertension who have difficulty controlling blood pressure with monotherapy of amlodipine or valsartan.
The recommended dose of this medication is 1 tablet once daily, taken with water, with or without food. It is recommended that it be taken at the same time each day, if possible (e.g., in the morning). Before starting this medication, it is recommended that the dose of each individual component (amlodipine or valsartan) be adjusted. However, switching directly to this medication may be considered if blood pressure is not adequately controlled with monotherapy using either component, as follows. ㆍ5/80 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or valsartan 80 milligrams monotherapy. ㆍ5/160 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or valsartan 160 milligrams monotherapy. ㆍ10/160 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 10 milligrams or valsartan 160 milligrams monotherapy, or with 5/160 milligrams. Patients taking valsartan and amlodipine concomitantly may switch to this medication (a combination product containing the same amounts of each active ingredient) for convenience. Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment (creatinine clearance 10mL/min or greater); however, this medication should not be administered to patients with severe renal impairment (creatinine clearance less than 10mL/min) or patients on dialysis. Monitoring of potassium levels and creatinine is recommended in patients with moderate renal impairment. Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of valsartan should not exceed 80mg. Do not administer this medication to patients with severe hepatic impairment, biliary cirrhosis, or biliary obstruction or cholestasis. Patients aged 65 years or older: Use caution when increasing the dose.
The safety and efficacy of this medication have not been established in pediatric patients under 18 years of age; therefore, its use is not recommended.
This medication may cause serious harm to the fetus or newborn if taken during the second or third trimester of pregnancy; it should be discontinued immediately once pregnancy is confirmed. It should not be used in patients with an allergy to the active ingredients or similar drug classes, women who are pregnant or breastfeeding, patients with severe kidney or liver disease, or patients with certain heart conditions. Patients who are deficient in sodium or fluid must manage their condition before taking this medication, and if symptoms of hypotension appear, they should be laid down immediately and may require fluid therapy. Patients with high potassium levels should take caution when taking this drug and potassium-increasing medications together, and potassium levels should be monitored frequently. Patients with renal artery stenosis or those who have recently undergone kidney transplantation should use this medication with caution, as it may affect kidney function. If symptoms of angioedema occur, use of the medication should be discontinued immediately, and it should not be readministered. Patients with heart failure or after myocardial infarction should be carefully monitored for changes in kidney function when taking this medication, and it is advisable not to combine it with certain drugs in heart failure patients. This medication may cause various adverse reactions, with common symptoms including headache, dizziness, swelling, fatigue, etc. Caution should be exercised when driving or operating machinery, as dizziness or fatigue may occur. When used in combination with other medications, there may be interactions, so consultation with a doctor or pharmacist is necessary, especially when used with certain antihypertensives, potassium supplements, or specific anti-inflammatory medications. Women who are pregnant or planning to become pregnant should not use this medication, and breastfeeding women are also advised to avoid its use. It is not recommended for children under 18 years of age, as safety and effectiveness have not been sufficiently established. Elderly patients may use similar dosages as adults, but their physical status should be closely monitored. Overdosage may lead to severe hypotension or cardiovascular abnormalities, requiring immediate medical attention. During treatment, it is important to regularly check blood pressure, kidney function, and electrolyte levels.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to protect it from air and moisture. The recommended storage temperature is room temperature between 1 to 30 degrees Celsius.
Bright yellow egg-shaped film-coated tablets
28 tablets (14 tablets/PTP packaging X 2), 30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
(株)Handok
CombinationValsartan 160mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Novartis Korea Co., Ltd.
CombinationValsartan 80mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Korea Novartis Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 13.87mg
Tablet · Prescription medication · Combination
Novartis Korea Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandose Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandos Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandos Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 13.87mg
Tablet · Prescription medication · Combination
Myungmoon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.